NACDS submitted a letter to the Colorado Department of Regulatory Agencies- Board of Pharmacy requesting a permanent waiver allowing pharmacists to independently order and administer COVID-19 tests, including serology tests, that have received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA), or equivalent regulatory authorization, subject to the disclaimers and limitations required by the FDA, in addition to any CLIA-waived point-of-care tests. NACDS also recommended that pharmacists may delegate the administration of any vaccines and immunizations, including vaccines authorized by the FDA to trained pharmacy interns or pharmacy technicians.
For more information, contact NACDS’ Mary Staples at 817-442-1155.